TAVI: Study shows 80% survival at 2 years for Direct Flow device

Direct Flow Medical says 2-year data from its Discover CE Mark trial showed an 80% survival rate at 2 years for its transcatheter aortic valve implant. Direct Flow Medical today said data from a clinical trial of its replacement heart valve showed an 80% survival rate after 2 years. Direct Flow Medical Inc.News Well, Clinical Trials, Replacement Heart Valvesread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news